Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$9.34M Sell
88,851
-5,292
-6% -$622K 0.69% 59
2025
Q4
$11.7M Sell
94,143
-37,311
-28% -$4.44M 0.76% 46
2025
Q3
$15.8M Sell
131,454
-12,323
-9% -$1.3M 0.98% 39
2025
Q2
$13.2M Sell
143,777
-4,865
-3% -$444K 0.91% 44
2025
Q1
$13.1M Sell
148,642
-41,996
-22% -$4.13M 0.94% 45
2024
Q4
$17.6M Sell
190,638
-7,297
-4% -$702K 1% 46
2024
Q3
$18.4M Sell
197,935
-5,574
-3% -$468K 1.02% 44
2024
Q2
$15.3M Buy
203,509
+526
+0.3% +$42K 0.9% 48
2024
Q1
$17.5M Sell
202,983
-2,492
-1% -$190K 0.95% 49
2023
Q4
$14.2M Buy
205,475
+33,067
+19% +$2M 0.77% 53
2023
Q3
$9.44M Buy
+172,408
New +$9.8M 0.53% 69
2015
Q1
Sell
-4,500
Closed -$108K 226
2014
Q4
$108K Buy
+4,500
New +$102K ﹤0.01% 208

Other funds holding CRH

Cramer Rosenthal McGlynn's CRH Position: Q1 2026 in Review

Cramer Rosenthal McGlynn reduced its CRH (CRH) stake by 5.6% in Q1 2026, selling an estimated $622K and leaving 88,851 shares worth $9.34M. The position accounts for 0.69% of the portfolio, ranked #59.

Cramer Rosenthal McGlynn first reported a position in CRH in Q4 2014 and has held it in 12 quarters since. The position peaked at $18.4M in Q3 2024. 1,006 funds tracked by Wall St. Rank hold CRH as of Q1 2026.

  • Cramer Rosenthal McGlynn held 88,851 shares of CRH worth $9.34M as of Q1 2026.
  • Cramer Rosenthal McGlynn sold 5,292 CRH shares in Q1 2026, an estimated $622K.
  • CRH made up 0.69% of Cramer Rosenthal McGlynn's portfolio in Q1 2026, its #59 holding.
  • Cramer Rosenthal McGlynn first reported a position in CRH in Q4 2014 and has held it in 12 quarters since.
  • Cramer Rosenthal McGlynn's CRH position peaked at $18.4M in Q3 2024.
  • 1,006 funds tracked by Wall St. Rank held CRH as of Q1 2026.

Based on Cramer Rosenthal McGlynn's 13F filing for Q1 2026, filed 15 May 2026.